- Home
- DRCT vs BFRI Comparison
DRCT vs BFRI Comparison
Compare DRCT & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRCT | BFRI |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 9.7M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DRCT | BFRI |
|---|---|---|
| Price | $0.07 | $0.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $6.00 | $2.75 |
| AVG Volume (30 Days) | ★ 24.1M | 103.6K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $35,369,000.00 | ★ $37,164,000.00 |
| Revenue This Year | N/A | $9.70 |
| Revenue Next Year | $25.40 | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.11 |
| 52 Week Low | $0.07 | $0.54 |
| 52 Week High | $6.59 | $1.87 |
Technical Indicators
Market Signals| Indicator | DRCT | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 22.58 | 42.05 |
| Support Level | $0.09 | $0.77 |
| Resistance Level | $0.09 | $0.83 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 3.26 | 41.70 |
Price Performance
Historical ComparisonAbout DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.